How four stability assessment technologies support biologics early development

August 10, 2023 Léa Valla

During early development of biologics, there are a large number of attributes researchers evaluate, but some of the most common center around stability – asking if a biologic is well-folded, active, and pure in its buffer, and whether it remains that way over time.

Biophysical characterization measurements from nanoDSF, DLS, backreflection, and SLS are valuable for providing this information without using a lot of material.

Read more to see how each of these technologies is helpful for characterization of your candidates during biologic development prior to clinical trials.

Worklfow infographic

Previous Article
Why nanoDSF is the preferred method to assess the thermal stability of your therapeutic proteins
Why nanoDSF is the preferred method to assess the thermal stability of your therapeutic proteins

Learn about Differential Scanning Calorimetry (DSC), Circular Dichroism (CD), Extrinsic Differential Scann...

Up next
How stability characterization parameters help you create biologics developability profiles
How stability characterization parameters help you create biologics developability profiles

Developability profiles help you avoid risk by collecting many quality attributes associated with each cand...

Ready to tackle your challenging stability characterizations?

Discover tools